Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Transfusion- Related Iron Overload (TRIO) Is Associated with Delayed Engraftment and Increased Non Relapse Mortality (NRM) in Patients Undergoing Umbilical Cord Blood (UCB) Hematopoietic Cell Transplantation (HCT)

Monzr M. Al Malki, MD, Joo Y. Song, MD, Dongyun Yang, PhD, Thai Cao, MD, Ibrahim Aldoss, MD, Sally Mokhtari, PhD, Sanjeet Dadwal, MD, Ketevan Gendzekhadze, PhD, Anna B Pawlowska, MD, Maryam Ameri, MD, Guido Marcucci, MD, Chatchada Karanes, Pablo Parker, MD, David S. Snyder, MD, David Senitzer, PhD, Auayporn P. Nademanee, MDBS, Stephen J. Forman, MD FACP, Ryotaro Nakamura, MD, Vinod Pullarkat, MD MRCP

Blood (2017) 130 (Supplement 1): 3212.

https://doi.org/10.1182/blood.V130.Suppl_1.3212.3212

Published: 2017

Journal Articles

High Incidence of CMV Reactivation after Haploidentical Donor Hematopoietic Cell Transplantation Using High-Dose Post-Transplant Cyclophosphamide, and Its Impact on Transplant Outcomes

Monzr M. Al Malki, MD, Sanjeet Dadwal, MD, Dongyun Yang, PhD, Sally Mokhtari, PhD, Thai Cao, MD, Ketevan Gendzekhadze, PhD, Ibrahim Aldoss, MD, Pablo Parker, MD, Margaret R. O'Donnell, MD, David S. Snyder, MD, David Senitzer, PhD, Joseph Rosenthal, MD MS, Auayporn P. Nademanee, MDBS, Don Diamond, PhD, John Zaia, MD, Stephen J. Forman, MD FACP, Ryotaro Nakamura, MD

Blood (2017) 130 (Supplement 1): 4494.

https://doi.org/10.1182/blood.V130.Suppl_1.4494.4494

Published: 2017

Journal Articles

Favorable Impact of Allogeneic Stem Cell Transplantation in Patients with Therapy-Related Myelodysplasia Regardless of TP53 Mutational Status

Blood (2017) 130 (Supplement 1): 4248.

https://doi.org/10.1182/blood.V130.Suppl_1.4248.4248

Published: 2017

Journal Articles

Reduced Relapse Risk in Acute Myelogenous Leukemia (AML) after Allogeneic Hematopoietic Stem Cell Transplantation (HCT) in Patients Who Experienced CMV Reactivation: Influence of Donor KIR Genotypes

Anthony Stein, Ketevan Gendzekhadze, PhD, Joycelynne Palmer, PhD, Ni-Chun Tsai, MS MPH, Sandra H. Thomas, PhD, Stephen J. Forman, John A. Zaia, MD, David Senitzer, PhD, Ryotaro Nakamura, MD

Blood (2014) 124 (21): 669.

https://doi.org/10.1182/blood.V124.21.669.669

Published: 2014

Journal Articles

Drug Metabolism Gene Polymorphisms Influence Tacrolimus/Sirolimus Blood Levels and Incidence of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation

Samer K Khaled, MD, Joycelynne Palmer, PhD, Josef Herzog, Tracey Stiller, MS, Ni-Chun Tsai, MS MPH, David Senitzer, PhD, Xueli Liu, PhD, Sandra H. Thomas, PhD, Sepideh Shayani, PharmD, Jeffrey Weitzel, MD, Stephen J. Forman, Ryotaro Nakamura, MD

Blood (2014) 124 (21): 2492.

https://doi.org/10.1182/blood.V124.21.2492.2492

Published: 2014

Journal Articles

Phase I Trial of Escalated Doses of Targeted Marrow Radiation Delivered by Tomotherapy Combined with Etoposide and Cyclophosphamide; An Allogeneic HCT Preparative Regimen for Patients with Advanced Leukemia

Anthony Selwyn Stein, MD, Jeffrey Wong, MD, Joycelynne Palmer, PhD, Margaret O'Donnell, MD, David S. Snyder, MD, Ni-Chun Tsai, MS MPH, Pablo Parker, MD, Len Farol, MD, Ricardo Spielberger, MD, Firoozeh Sahebi, MD, Neil Kogut, MD, Joyce Murata-Collins, PhD, David Senitzer, PhD, Stephen J. Forman, MD

Blood (2012) 120 (21): 218.

https://doi.org/10.1182/blood.V120.21.218.218

Published: 2012

Journal Articles

Genetic Susceptibility to Anthracycline-Related Congestive Heart Failure (CHF) in Survivors of Hematopoietic Cell Transplantation (HCT)

Saro H. Armenian, DO, MPH, Yan Ding, PhD, George Mills, III, Can-Lan Sun, PhD, Kalyanasundaram Venkatraman, MD, F. Lennie Wong, PhD, David Senitzer, PhD, Shirong Wang, MD, Stephen J. Forman, MD, Smita Bhatia, MD, MPH

Blood (2012) 120 (21): 589.

https://doi.org/10.1182/blood.V120.21.589.589

Published: 2012

Journal Articles

Detection and Characterization of Antigen-Driven CD8 + T Lymphocytes Specific for Wilms' Tumor Antigen in Patients with Non-Hodgkin Lymphoma

Ryotaro Nakamura, MD, Anna Israyelyan, MD, PhD, Corinna La Rosa, PhD, Weimin Tsai, BS, Teodora Kaltcheva, PhD, Tumul Srivastava, PhD, Jessica Lo, BS, Lia Aquino, Jianqiang Li, PhD, Young Kim, MD, Joycelynne Palmer, PhD, David Senitzer, PhD, John Zaia, MD, Stephen J. Forman, MD, Don J. Diamond, PhD

Blood (2011) 118 (21): 953.

https://doi.org/10.1182/blood.V118.21.953.953

Published: 2011

Journal Articles

A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimens

Roberto Rodriguez, Ryotaro Nakamura, Joycelynne M. Palmer, Pablo Parker, Sepideh Shayani, Auyaporn Nademanee, David Snyder, Vinod Pullarkat, Neil Kogut, Joseph Rosenthal, Eileen Smith, Chatchada Karanes, Margaret O'Donnell, Amrita Y. Krishnan, David Senitzer, Stephen J. Forman

Blood (2010) 115 (5): 1098–1105.

https://doi.org/10.1182/blood-2009-03-207563

Published: 2010

Journal Articles

Improved Outcome After Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation (RI-HCT) for Myelodysplastic Syndrome (MDS) Using Tacrolimus/Sirolimus-Based Gvhd Prophylaxis.

Ryotaro Nakamura, MD, Joycelynne Palmer, Pablo Parker, Anthony Stein, Tracey Stiller, Vinod Pullarkat, David S. Snyder, MD, Ji-Lian Cai, MD, PhD, Shirong Wang, MD, MPH, David Senitzer, PhD, Karen L. Chang, Ravi Bhatia, Stephen J Forman, MD, Margaret O'Donnell, MD

Blood (2009) 114 (22): 2771.

https://doi.org/10.1182/blood.V114.22.2771.2771

Published: 2009

Journal Articles

Thrombotic Microangiopathy with Tacrolimus/Sirolimus-Based GVHD Prophylaxis Regimen in Patients Undergoing Hematopoietic Stem Cell Transplant from a Matched Unrelated Donor

Tam Khuu, PharmD, Sepideh Shayani, PharmD, Joycelynne Palmer, PhD, Roberto Rodriguez, MD, Pablo Miguel Parker, David S. Snyder, MD, Vinod Pullarkat, Joseph Rosenthal, Auayporn P. Nademanee, David Senitzer, PhD, Ryotaro Nakamura, MD, Stephen J. Forman

Blood (2008) 112 (11): 797.

https://doi.org/10.1182/blood.V112.11.797.797

Published: 2008

Journal Articles

Chemokine Receptor Gene Polymorphisms and Severity of Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation from Sibling Donors.

Vinod Pullarkat, MD, Jiyao Sun, MD, Fangxin Hong, PhD, Ryotaro Nakamura, MD, Lan-Feng Cao, BS, Joycelynn Palmer, PhD, Stephen J. Forman, MD, David Senitzer, PhD

Blood (2007) 110 (11): 4989.

https://doi.org/10.1182/blood.V110.11.4989.4989

Published: 2007

Journal Articles

The Use of Sirolimus Combined with Tacrolimus and Low-Dose Methotrexate Is Effective in Preventing Graft-Versus-Host Disease after Unrelated Donor Hematopoietic Stem Cell Transplantation.

Ryotaro Nakamura, MD, Roberto Rodriguez, MD, Auayporn Nademanee, MD, Joycelynne Palmer, PhD, David Senitzer, PhD, David Snyder, MD, Jasmine Zain, MD, Vinod Pullarkat, MD, Stephen J. Forman, MD, Pablo Miguel Parker, MD

Blood (2006) 108 (11): 2866.

https://doi.org/10.1182/blood.V108.11.2866.2866

Published: 2006

Journal Articles

Tacrolimus and Sirolimus as GVHD Prophylaxis for HLA-MRD Allogeneic HCT Conditioned with 3 Regimens: Toxicity and Efficacy in 70 Patients.

Roberto Rodriguez, MD, Joycelynne Palmer, PhD, Ryotaro Nakamura, MD, Pablo Miguel Parker, MD, Auayporn P. Nademanee, MD, David S. Snyder, MD, Vinod Pullarkat, MD, Jasmine M. Zain, MD, Ricardo Spielberger, MD, David Senitzer, PhD, Stephen J. Forman, MD

Blood (2006) 108 (11): 2867.

https://doi.org/10.1182/blood.V108.11.2867.2867

Published: 2006

Journal Articles

Transplant CD34+ Cell Dose Affects Outcomes Following Allogeneic Peripheral Blood Stem Cell Transplantation from a Matched Unrelated Donor.

Ryotaro Nakamura, MD, Joycelynne Palmer, PhD, Roberto Rodriguez, MD, Pablo Parker, MD, David Senitzer, PhD, Anthony Stein, MD, Josheph Rosenthal, MD, Sean Wang, MD, Jeffrey Schriber, MD, Stephen J. Forman, MD, Auayporn Nademanee, MD

Blood (2005) 106 (11): 2056.

https://doi.org/10.1182/blood.V106.11.2056.2056

Published: 2005

Journal Articles

Evidence of Donor Derived Malignancies Following Hematopoietic Stem Cell Transplantation.

Olga Sala-Torra, M.D., Michael R. Loken, Ph.D., Mary E.D. Flowers, M.D., Paula A. Ladne, M.S., James Mason, M.D, David Senitzer, Ph.D., Stephen J. Forman, M.D., Jerald Radich, M.D.

Blood (2004) 104 (11): 2247.

https://doi.org/10.1182/blood.V104.11.2247.2247

Published: 2004

NARROW

Transfusion- Related Iron Overload (TRIO) Is Associated with Delayed Engraftment and Increased Non Relapse Mortality (NRM) in Patients Undergoing Umbilical Cord Blood (UCB) Hematopoietic Cell Transplantation (HCT)

High Incidence of CMV Reactivation after Haploidentical Donor Hematopoietic Cell Transplantation Using High-Dose Post-Transplant Cyclophosphamide, and Its Impact on Transplant Outcomes

Favorable Impact of Allogeneic Stem Cell Transplantation in Patients with Therapy-Related Myelodysplasia Regardless of TP53 Mutational Status

Reduced Relapse Risk in Acute Myelogenous Leukemia (AML) after Allogeneic Hematopoietic Stem Cell Transplantation (HCT) in Patients Who Experienced CMV Reactivation: Influence of Donor KIR Genotypes

Drug Metabolism Gene Polymorphisms Influence Tacrolimus/Sirolimus Blood Levels and Incidence of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation

Phase I Trial of Escalated Doses of Targeted Marrow Radiation Delivered by Tomotherapy Combined with Etoposide and Cyclophosphamide; An Allogeneic HCT Preparative Regimen for Patients with Advanced Leukemia

Genetic Susceptibility to Anthracycline-Related Congestive Heart Failure (CHF) in Survivors of Hematopoietic Cell Transplantation (HCT)

Detection and Characterization of Antigen-Driven CD8 + T Lymphocytes Specific for Wilms' Tumor Antigen in Patients with Non-Hodgkin Lymphoma

A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimens

Improved Outcome After Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation (RI-HCT) for Myelodysplastic Syndrome (MDS) Using Tacrolimus/Sirolimus-Based Gvhd Prophylaxis.

Thrombotic Microangiopathy with Tacrolimus/Sirolimus-Based GVHD Prophylaxis Regimen in Patients Undergoing Hematopoietic Stem Cell Transplant from a Matched Unrelated Donor

Chemokine Receptor Gene Polymorphisms and Severity of Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation from Sibling Donors.

The Use of Sirolimus Combined with Tacrolimus and Low-Dose Methotrexate Is Effective in Preventing Graft-Versus-Host Disease after Unrelated Donor Hematopoietic Stem Cell Transplantation.

Tacrolimus and Sirolimus as GVHD Prophylaxis for HLA-MRD Allogeneic HCT Conditioned with 3 Regimens: Toxicity and Efficacy in 70 Patients.

Transplant CD34+ Cell Dose Affects Outcomes Following Allogeneic Peripheral Blood Stem Cell Transplantation from a Matched Unrelated Donor.

Evidence of Donor Derived Malignancies Following Hematopoietic Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only